Kelsey Stephen Michael (CIK 1462808) reported 26 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-18). Recent activity: Sell RVMD (85 shares), Sell RVMD (5,484 shares), Buy RVMD (52,500 shares), Buy RVMD (40,031 shares), Sell RVMD (800 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | Revolution Medicines, Inc. (RVMD) | Senior Advisor to the Chief Executive Officer | Sell | 85 | $16,576 |
| 2026-09-18 | Revolution Medicines, Inc. (RVMD) | Senior Advisor to the Chief Executive Officer | Sell | 5,484 | $1.1M |
| 2026-09-15 | Revolution Medicines, Inc. (RVMD) | Senior Advisor to the Chief Executive Officer | Buy | 52,500 | $2.2M |
| 2026-09-15 | Revolution Medicines, Inc. (RVMD) | Senior Advisor to the Chief Executive Officer | Buy | 40,031 | $1.6M |
| 2026-09-15 | Revolution Medicines, Inc. (RVMD) | Senior Advisor to the Chief Executive Officer | Sell | 800 | $158,840 |
| 2026-09-15 | Revolution Medicines, Inc. (RVMD) | Senior Advisor to the Chief Executive Officer | Sell | 11,833 | $2.4M |
| 2026-09-15 | Revolution Medicines, Inc. (RVMD) | Senior Advisor to the Chief Executive Officer | Sell | 13,368 | $2.7M |
| 2026-09-15 | Revolution Medicines, Inc. (RVMD) | Senior Advisor to the Chief Executive Officer | Sell | 21,447 | $4.3M |
| 2026-09-15 | Revolution Medicines, Inc. (RVMD) | Senior Advisor to the Chief Executive Officer | Sell | 18,869 | $3.8M |
| 2026-09-15 | Revolution Medicines, Inc. (RVMD) | Senior Advisor to the Chief Executive Officer | Sell | 17,949 | $3.7M |
| 2026-09-15 | Revolution Medicines, Inc. (RVMD) | Senior Advisor to the Chief Executive Officer | Sell | 4,995 | $1.0M |
| 2026-09-15 | Revolution Medicines, Inc. (RVMD) | Senior Advisor to the Chief Executive Officer | Sell | 3,270 | $672,991 |
| 2026-06-18 | Revolution Medicines, Inc. (RVMD) | President, Research and Development | Sell | 4,175 | $651,801 |
| 2026-03-19 | Revolution Medicines, Inc. (RVMD) | President, Research and Development | Sell | 4,302 | $427,963 |
| 2026-03-03 | Revolution Medicines, Inc. (RVMD) | President, Research and Development | Buy | 21,100 | $0 |
| 2025-12-18 | Revolution Medicines, Inc. (RVMD) | President, Research and Development | Sell | 5,447 | $418,439 |
| 2025-10-15 | Revolution Medicines, Inc. (RVMD) | President, Research and Development | Buy | 25,000 | $118,250 |
| 2025-10-15 | Revolution Medicines, Inc. (RVMD) | President, Research and Development | Sell | 25,000 | $1.2M |
| 2025-09-18 | Revolution Medicines, Inc. (RVMD) | President, Research and Development | Sell | 5,367 | $245,916 |
| 2025-09-15 | Revolution Medicines, Inc. (RVMD) | President, Research and Development | Buy | 100,000 | $473,000 |
| 2025-09-15 | Revolution Medicines, Inc. (RVMD) | President, Research and Development | Sell | 44,059 | $1.9M |
| 2025-09-15 | Revolution Medicines, Inc. (RVMD) | President, Research and Development | Sell | 55,941 | $2.5M |
| 2025-09-15 | Revolution Medicines, Inc. (RVMD) | President, Research and Development | Buy | 25,000 | $118,250 |
| 2025-09-15 | Revolution Medicines, Inc. (RVMD) | President, Research and Development | Sell | 23,682 | $1.1M |
| 2025-09-15 | Revolution Medicines, Inc. (RVMD) | President, Research and Development | Sell | 1,318 | $61,854 |
来源：SEC Form 4 申报文件 · 截至 2026-09-18